Skip to main content
Caplight Logo









Qmed Asia

Qmed Asia

Private
Kuala LumpurHealthcare & Life Scienceshttps://qmed.asia/en

Last Round

Crowdfunding

Apr 5, 2023

Est. Valuation

$23.77M

Total Funding Raised

$1.63M

Company Overview

Qmed Asia is a health-tech company that provides a comprehensive suite of SaaS solutions for healthcare providers, including appointment booking, mobile queuing systems, teleconsultations, and AI-powered clinical assistants.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Telemedicine, Patient Engagement, Medical AI, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

healthtechdigital healthclinical decision supporthospital management systemHMSelectronic medical recordsEMRtelemedicinepatient engagementclinical AImedical scribeAI scribequeue managementremote patient monitoringRPMvertical SaaStelehealth kioskmedical imaging analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qmed Asia Comparables

Compare Qmed Asia with similar companies based on industry and business-model similarity.

Qmed Asia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Invitrace Company Limited
81%
Bot MD
80%
Heals Healthcare
79%

Qmed Asia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingApr 5, 2023
AngelDec 31, 2021
GrantDec 1, 2021

Key People

Founding team and executive leadership

Kev Lim

Chief Executive Officer

Executive Team

Qmed Asia Investors

Notable investors and investment history

Qmed Asia investors
InvestorRounds
1337 VenturesCrowdfunding
Cradle FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 31, 2021

    $360K raised in an angel round.

  • Dec 1, 2021

    $108K grant received from Cradle Fund.

Recent news

Latest coverage and updates

  • partners_withAug 11, 2026

    Qmed partnered with Intel Corporation on Aug 6th '26.

Qmed Asia Filings

Explore SEC and related filing metadata, where available.

Qmed Asia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Qmed Asia's valuation, stock price, and market status.

Is Qmed Asia a public or private company?

Qmed Asia is a private company.

What is the current stock price of Qmed Asia?

Qmed Asia is a private company with no public stock price. No recent secondary market data is available.

How much is Qmed Asia worth (valuation)?

Valuation information for Qmed Asia is not publicly available.

Can I buy Qmed Asia stock?

Qmed Asia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Qmed Asia's last funding round?

Qmed Asia's most recent funding round was Crowdfunding on April 5, 2023.

Who are the main investors in Qmed Asia?

Key investors in Qmed Asia include 1337 Ventures.

Will Qmed Asia IPO soon?

No public IPO plans have been announced for Qmed Asia.

How can I track Qmed Asia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qmed Asia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKuala Lumpur
Employee Range25
Year Founded2019
Last FundingApr 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?